Downregulation of stromal syntenin sustains AML development
R. Leblanc, R. Ghossoub, A. Goubard, R. Castellano, J. Fares, L. Camoin, S. Audebert, M. Balzano, B. Boutayeh, C. Fauriat, N. Vey, J.-P. Borg, Y. Collette, M. Aurrand-Lions, G. David, P. Zimmermann
This study shows that reduced stromal syntenin in bone marrow stromal cells promotes AML aggressiveness by enhancing AML cell survival and protein synthesis through endoglin upregulation.
bioRxiv · Feb 15, 2023Cancer Biology